Emcure Pharmaceuticals Limited (NSE:EMCURE)
India
· Delayed Price · Currency is INR 1,361.40
-14.50 (-1.05%)
At close: Jun 13, 2025, 3:30 PM IST
Emcure Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Net Income | 6,813 | 4,982 | 5,320 | 6,622 | 3,921 | Upgrade
|
| Depreciation & Amortization | 3,841 | 3,032 | 2,512 | 2,348 | 3,137 | Upgrade
|
| Other Amortization | - | 92.56 | 89.04 | 100.28 | 96.1 | Upgrade
|
| Loss (Gain) From Sale of Assets | -382.35 | -71.92 | 3.33 | 4.08 | -4.23 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 436.95 | Upgrade
|
| Loss (Gain) From Sale of Investments | -58.04 | -25.32 | -1.21 | - | - | Upgrade
|
| Stock-Based Compensation | 19.89 | 39.67 | 52.76 | 57.16 | 63.48 | Upgrade
|
| Other Operating Activities | 2,526 | 2,419 | 2,415 | 1,469 | 4,573 | Upgrade
|
| Change in Accounts Receivable | -1,434 | -1,506 | -3,398 | -1,729 | -3,301 | Upgrade
|
| Change in Inventory | -4,067 | -267.61 | 663.85 | -3,072 | -3,413 | Upgrade
|
| Change in Accounts Payable | 1,702 | 1,543 | -391.8 | 3,157 | 2,315 | Upgrade
|
| Change in Other Net Operating Assets | -443.61 | 736.2 | 203.54 | -1,276 | 1,053 | Upgrade
|
| Operating Cash Flow | 8,517 | 10,972 | 7,469 | 7,682 | 7,044 | Upgrade
|
| Operating Cash Flow Growth | -22.38% | 46.91% | -2.78% | 9.05% | 40.80% | Upgrade
|
| Capital Expenditures | -2,218 | -2,758 | -3,906 | -3,782 | -1,254 | Upgrade
|
| Sale of Property, Plant & Equipment | 306.01 | 315.37 | 12.75 | 31.21 | 125.14 | Upgrade
|
| Cash Acquisitions | - | -3,451 | - | -2,751 | -1,116 | Upgrade
|
| Sale (Purchase) of Intangibles | -1,852 | -313.6 | -127.67 | -187.87 | -202.65 | Upgrade
|
| Investment in Securities | 2,592 | -1,098 | -708.36 | -1,308 | -147.22 | Upgrade
|
| Other Investing Activities | 231.44 | 179.46 | 152.4 | 109.49 | 75.81 | Upgrade
|
| Investing Cash Flow | -940.01 | -7,125 | -4,577 | -7,888 | -2,518 | Upgrade
|
| Short-Term Debt Issued | - | 1,025 | 976.79 | 1,759 | - | Upgrade
|
| Long-Term Debt Issued | - | 5,474 | 3,576 | 3,714 | 5,775 | Upgrade
|
| Total Debt Issued | - | 6,500 | 4,553 | 5,473 | 5,775 | Upgrade
|
| Short-Term Debt Repaid | -5,225 | - | - | - | -981.67 | Upgrade
|
| Long-Term Debt Repaid | -9,420 | -5,310 | -3,777 | -4,814 | -4,548 | Upgrade
|
| Total Debt Repaid | -14,645 | -5,310 | -3,777 | -4,814 | -5,529 | Upgrade
|
| Net Debt Issued (Repaid) | -14,645 | 1,190 | 775.24 | 659.17 | 245.66 | Upgrade
|
| Issuance of Common Stock | 7,792 | 76.6 | - | - | - | Upgrade
|
| Common Dividends Paid | - | -542.55 | -361.71 | -542.55 | -180.85 | Upgrade
|
| Other Financing Activities | -1,287 | -2,366 | -1,868 | -1,635 | -1,954 | Upgrade
|
| Financing Cash Flow | -8,140 | -1,642 | -1,454 | -1,519 | -1,889 | Upgrade
|
| Foreign Exchange Rate Adjustments | -20.49 | -20.02 | -1.28 | 1.86 | -46.17 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -100 | 2,141 | - | Upgrade
|
| Net Cash Flow | -583.02 | 2,185 | 1,336 | 418.7 | 2,591 | Upgrade
|
| Free Cash Flow | 6,299 | 8,215 | 3,563 | 3,900 | 5,790 | Upgrade
|
| Free Cash Flow Growth | -23.32% | 130.58% | -8.65% | -32.65% | 50.40% | Upgrade
|
| Free Cash Flow Margin | 7.98% | 12.34% | 5.95% | 6.66% | 11.50% | Upgrade
|
| Free Cash Flow Per Share | 33.68 | 45.42 | 19.70 | 21.57 | 32.02 | Upgrade
|
| Cash Interest Paid | 1,287 | 2,082 | 1,786 | 1,553 | 1,845 | Upgrade
|
| Cash Income Tax Paid | 2,469 | 2,237 | 2,005 | 3,112 | 2,004 | Upgrade
|
| Levered Free Cash Flow | 2,590 | 3,722 | 1,763 | 2,388 | 5,053 | Upgrade
|
| Unlevered Free Cash Flow | 3,688 | 4,940 | 2,781 | 3,216 | 5,765 | Upgrade
|
| Change in Net Working Capital | 2,883 | 885.42 | 1,598 | 2,104 | 2,092 | Upgrade
|
Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.